The increasing demand for enzymes as pharmaceutical products is driving the global “enzymes market 2020”, says Fortune Business Insights in a report titled “Enzymes Market Size, Share And Global Trend By Type (Cellulases,Amylases, Proteases, Lipases, Other), By Source (Bacterial, Fungal, Yeast), By Application (Pharmaceutical Industries, Diagnostics Laboratories, Food Industries, Cosmetic Industries, Others), By End User (Pharmaceutical Industries ,Biotechnological Companies, Diagnostic Clinics, Education & Research Institutes, Others), And Geography Forecast Till 2026.” Rising application of enzyme in the diagnosis of diseases is a key factor supporting the growth of the global enzymes market.
Key Players Operating in The Enzymes Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are BASF, Codexis Inc., Amano Enzyme Inc., DSM, Dupont De Nemours & Co., ABF PLC, AB Enzymes, Dyadic International Inc., Advanced Enzyme Technology Ltd., Affymetrix Inc., Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Roche Holding Ag., Sanofi S.A., and others.
Request a Sample Copy of the Global Enzymes Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/enzymes-market-100595
Launch of Articzymes’s First Ligase Enzyme Will Aid Growth
Biotec Pharmacon, a biotechnology company launched its first ligase enzyme, T4 DNA ligase through a subsidiary ArcticZymes. T4 DNA ligase is mostly used in the development of kits and products serving the In Vitro Diagnostic (IVD) and molecular research. The launch of T4 DNA ligase is predicted to promote the properties of enzymes owing to the strict ISO 13485 guidelines. This factor will, in turn, contribute growth to the global enzymes market. Further, the launch of the insulin-degrading enzyme is also predicted to contribute growth to the global enzymes revenue. For instance, Creative Enzymes launched the insulin-degrading enzyme also referred to as insulin protease or insulysin for the researchers working in the life sciences industry.
Presence of Leading Companies Will Stimulate Growth in North America
Geographically, the global enzymes market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are predicted to dominate the global enzymes market during the forecast period owing to the presence of key biopharmaceutical companies in the region. Further, the rising investments by key players in research & development activities for the development of potent specialty enzymes is predicted to further boost the enzyme growth in the region. Asia Pacific is predicted to grow at a considerable rate during the forecast period owing to the increasing applications of enzymes in the pharmaceutical industry in emerging nations such as India, China and others.
Detailed Table of Content:
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
More Trending Topics from Fortune Business Insights: